# PHYHD1

## Overview
PHYHD1 is a gene that encodes the protein phytanoyl-CoA dioxygenase domain containing 1, which is a member of the 2-oxoglutarate-dependent oxygenase family. This protein is involved in fatty acid metabolism, specifically through its role in the oxidation of phytanoyl-CoA, a process crucial for the breakdown of certain fatty acids. As a non-heme Fe(II) enzyme, PHYHD1 shares structural similarities with other enzymes in its class, characterized by a dioxygenase domain that facilitates its enzymatic activity (Kemege2011Ab; Schofield2007Structural). Unlike its closest human homologue, PhyH, PHYHD1 lacks a peroxisomal-targeting sequence, suggesting a unique subcellular localization and function (Schofield2007Structural). The gene has been implicated in various diseases, including Alzheimer's disease and certain cancers, where its expression and methylation status may serve as potential biomarkers for disease progression and prognosis (Cui2020Identification; Yu2024DiseaseAssociated).

## Structure
The PHYHD1 protein, encoded by the human PHYHD1 gene, is characterized by its involvement in fatty acid metabolism, specifically through its dioxygenase domain. This domain is crucial for its enzymatic activity, facilitating the oxidation of substrates such as phytanoyl-CoA. The protein structure includes a combination of alpha-helices and beta-sheets, which are common features in its secondary structure (Kemege2011Ab). The tertiary structure of PHYHD1 involves the overall 3D folding that supports its function as a 2-oxoglutarate-dependent oxygenase, a characteristic shared with other non-heme Fe(II) enzymes (Kemege2011Ab).

PHYHD1 is structurally similar to the Chlamydia trachomatis protein CT296, which also shares a scaffold with non-heme Fe(II) 2-oxoglutarate-dependent enzymes, indicating a conserved structural framework (Kemege2011Ab). The protein does not have a peroxisomal-targeting sequence, which distinguishes it from its closest human homologue, PhyH (Schofield2007Structural). The absence of this sequence suggests a different subcellular localization and potentially distinct functional roles within the cell. The structural analysis of PHYHD1 highlights its evolutionary relationship with a subfamily of CoA-binding/oxidizing 2OG-dependent oxygenases (Schofield2007Structural).

## Clinical Significance
Alterations in the PHYHD1 gene have been implicated in several diseases and conditions. In Alzheimer's disease (AD), PHYHD1 is significantly upregulated in neurotoxic astrocytes and is associated with amyloid-beta clearance, suggesting its involvement in AD pathology through modulation of immune responses and cytokine signaling pathways (Castillo2017Comparative; Yu2024DiseaseAssociated). The gene's expression is linked to AD pathological indicators such as alpha-secretase and gamma-secretase activities, and its increased expression correlates with amyloidosis progression in mouse models (Castillo2017Comparative).

In laryngeal squamous cell carcinoma (LSCC), PHYHD1 is identified as a methylation-driven gene, where its hypermethylation and low expression are correlated with poor prognosis. This gene is part of a prognostic signature that predicts recurrence-free survival, outperforming traditional TNM staging (Cui2020Identification).

In non-functioning pituitary adenomas (NFPA), PHYHD1 shows increased DNA methylation and decreased expression in invasive tumors, indicating its potential role in tumor invasion (Cheng2019Identification). These findings suggest that PHYHD1 may serve as a biomarker and potential therapeutic target in various diseases.


## References


[1. (Yu2024DiseaseAssociated) Wuhan Yu, Yin Li, Fuxin Zhong, Zhangjing Deng, Jiani Wu, Weihua Yu, and Yang Lü. Disease-associated neurotoxic astrocyte markers in alzheimer disease based on integrative single-nucleus rna sequencing. Cellular and Molecular Neurobiology, February 2024. URL: http://dx.doi.org/10.1007/s10571-024-01453-w, doi:10.1007/s10571-024-01453-w. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10571-024-01453-w)

[2. (Kemege2011Ab) K. E. Kemege, J. M. Hickey, S. Lovell, K. P. Battaile, Y. Zhang, and P. S. Hefty. Ab initio structural modeling of and experimental validation for chlamydia trachomatis protein ct296 reveal structural similarity to fe(ii) 2-oxoglutarate-dependent enzymes. Journal of Bacteriology, 193(23):6517–6528, September 2011. URL: http://dx.doi.org/10.1128/jb.05488-11, doi:10.1128/jb.05488-11. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1128/jb.05488-11)

[3. (Schofield2007Structural) C.J. Schofield and M.A. McDonough. Structural and mechanistic studies on the peroxisomal oxygenase phytanoyl-coa 2-hydroxylase (phyh). Biochemical Society Transactions, 35(5):870–875, October 2007. URL: http://dx.doi.org/10.1042/bst0350870, doi:10.1042/bst0350870. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1042/bst0350870)

[4. (Cheng2019Identification) Sen Cheng, Weiyan Xie, Yazhou Miao, Jing Guo, Jichao Wang, Chuzhong Li, and Yazhuo Zhang. Identification of key genes in invasive clinically non-functioning pituitary adenoma by integrating analysis of dna methylation and mrna expression profiles. Journal of Translational Medicine, December 2019. URL: http://dx.doi.org/10.1186/s12967-019-02148-3, doi:10.1186/s12967-019-02148-3. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12967-019-02148-3)

[5. (Cui2020Identification) Jie Cui, Liping Wang, Waisheng Zhong, Zhen Chen, Jie Chen, Hong Yang, and Genglong Liu. Identification and validation of methylation-driven genes prognostic signature for recurrence of laryngeal squamous cell carcinoma by integrated bioinformatics analysis. Cancer Cell International, September 2020. URL: http://dx.doi.org/10.1186/s12935-020-01567-3, doi:10.1186/s12935-020-01567-3. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-020-01567-3)

[6. (Castillo2017Comparative) Erika Castillo, Julio Leon, Guianfranco Mazzei, Nona Abolhassani, Naoki Haruyama, Takashi Saito, Takaomi Saido, Masaaki Hokama, Toru Iwaki, Tomoyuki Ohara, Toshiharu Ninomiya, Yutaka Kiyohara, Kunihiko Sakumi, Frank M. LaFerla, and Yusaku Nakabeppu. Comparative profiling of cortical gene expression in alzheimer’s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation. Scientific Reports, December 2017. URL: http://dx.doi.org/10.1038/s41598-017-17999-3, doi:10.1038/s41598-017-17999-3. This article has 125 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-017-17999-3)